Collectively, we proved that pirfenidone blocks TGF-β1-induced fibrotic changes via the inhibition of the canonical Smad2/3 signaling pathway as well as the reduction in CEMIP expression levels, thus ameliorating the tumor mechano-environment. Here, SMAD2 is linked to neoplasm.